Related Experiment Video
Updated: Mar 28, 2026

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G-quadruplex
Peter Podbevšek1, Janez Plavec2
1Slovenian NMR Center, National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, Slovenia EN-FIST Centre of Excellence, Trg OF 13, SI-1000 Ljubljana, Slovenia.
Abstract:
Mutations of the KRAS proto-oncogene are associated with several tumor types, which is why it is being considered as a target for anti-cancer drug development. The human KRAS promoter contains a nuclease hypersensitive element (NHE), which can bind to nuclear proteins and is believed to form G-quadruplex structures. Previous studies showed that a 32-nt oligonucleotide (32R-3n) mimicking the KRAS NHE can reduce gene transcription by sequestering MAZ, a crucial transcription factor. Here we show that 32R-3n has to dimerize in order to fold into a G-quadruplex structure. Individual 5'- and 3'-end G-quadruplex units are formed and both feature a symmetric head-to-head topology with edge-type loops. The MAZ binding sequence is located within the 3'-end unit. Nuclear magnetic resonance data complemented by CD and UV spectra show that nucleotides of the MAZ binding G-rich motif are dynamic and could be available for sequence or structure based recognition. Both stable G-quadruplex structures could protect 5'- and 3'-ends of 32R-3n and enhance its anti-cancer activity. Single stranded genomic KRAS NHE including nucleotides flanking the 32R-3n sequence could favor a different monomeric fold, which remains unknown.
Insights
The KRAS NHE G-quadruplex structure requires dimerization for anti-cancer activity. This G-quadruplex formation protects the oligonucleotide and enhances its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Biophysics
Background:
- KRAS proto-oncogene mutations are linked to various cancers, making it a key target for anti-cancer drug development.
- The human KRAS promoter possesses a nuclease-hypersensitive element (NHE) that binds nuclear proteins and forms G-quadruplex structures.
- A 32-nt oligonucleotide (32R-3n) mimicking the KRAS NHE inhibits gene transcription by sequestering the transcription factor MAZ.
Purpose of the Study:
- To investigate the structural requirements of the 32R-3n oligonucleotide for G-quadruplex formation.
- To elucidate the role of G-quadruplex structure in the anti-cancer activity of 32R-3n.
- To characterize the MAZ binding site within the KRAS NHE G-quadruplex.
Main Methods:
- Nuclear magnetic resonance (NMR) spectroscopy
- Circular dichroism (CD) and UV spectroscopy
- Oligonucleotide synthesis and biophysical characterization
Main Results:
- The 32R-3n oligonucleotide must dimerize to form a stable G-quadruplex structure.
- The G-quadruplex features two symmetric 5'- and 3'-end units with head-to-head topology and edge-type loops.
- The MAZ binding site is located within the 3'-end G-quadruplex unit, and its nucleotides exhibit dynamic properties.
- Both G-quadruplex units contribute to the stability and anti-cancer efficacy of 32R-3n.
Conclusions:
- Dimerization is essential for the KRAS NHE mimic 32R-3n to fold into a functional G-quadruplex.
- The dynamic nature of the MAZ binding site suggests potential for sequence- or structure-based recognition.
- The stable dimeric G-quadruplex structure enhances the anti-cancer potential of 32R-3n by protecting its ends.
More Related Videos
Related Concept Videos
Cooperative Binding of Transcription Regulators
Bacterial Transcription
Transcription can be divided into three main stages, each involving distinct DNA sequences to guide the polymerase. These are:
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...

